Could a simple steroid shot make hip surgery recovery easier?
NCT ID NCT05023369
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether injecting the steroid dexamethasone around the hip joint during surgery can reduce pain, nausea, and hospital stay for people with a broken hip. About 110 adults aged 50-90 having hip replacement for a femoral neck fracture will take part. The goal is to see if this simple addition to standard care improves recovery without causing extra side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexamethasone (a steroid drug)
- What this could lead to
- If it works, this could offer a simple, low-cost way to improve recovery and reduce hospital stays for hip fracture patients.
- What could go wrong
- This is a small, early-phase trial with only 110 people, so results may not apply to everyone. Steroids carry risks like infection or delayed healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMORAL NECK FRACTURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Christian Candrian
RECRUITINGLugano, 6900, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hip fracture fixation device put to the test against traditional screws
- Anesthesia choice may influence blood loss in hip fracture surgery
- Hip replacement study reveals hidden socket damage risk
- Hip implant under the microscope: how does the tipmed system hold up in daily use?
- ER study: which nerve block eases hip fracture pain best?
- New hip stem implant tracked for 10 years in 313 patients